These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31369176)

  • 21. Nanomedicines in Diagnosis and Treatment of Cancer: An Update.
    Haider N; Fatima S; Taha M; Rizwanullah M; Firdous J; Ahmad R; Mazhar F; Khan MA
    Curr Pharm Des; 2020; 26(11):1216-1231. PubMed ID: 32188379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Image-guided tumor surgery: will there be a role for fluorescent nanoparticles?
    Hill TK; Mohs AM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Jul; 8(4):498-511. PubMed ID: 26585556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Organic Dye Based Nanoparticles for Cancer Phototheranostics.
    Cai Y; Si W; Huang W; Chen P; Shao J; Dong X
    Small; 2018 Jun; 14(25):e1704247. PubMed ID: 29611290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor versus Tumor Cell Targeting in Metal-Based Nanoparticles for Cancer Theranostics.
    Urbano-Gámez JD; Guzzi C; Bernal M; Solivera J; Martínez-Zubiaurre I; Caro C; García-Martín ML
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Near-Infrared Fluorescent Dye-Decorated Nanocages to Form Grenade-like Nanoparticles with Dual Control Release for Photothermal Theranostics and Chemotherapy.
    Lin CY; Shieh MJ
    Bioconjug Chem; 2018 Apr; 29(4):1384-1398. PubMed ID: 29505243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts.
    Huang Q; Ge Y; He Y; Wu J; Tong Y; Shang H; Liu X; Ba X; Xia D; Peng E; Chen Z; Tang K
    Int J Nanomedicine; 2024; 19():3333-3365. PubMed ID: 38617796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addressing Cancer Chemotherapeutic Toxicity, Resistance, and Heterogeneity: Novel Theranostic Use of DNA-Encoded Small Molecule Libraries.
    Kolodny G; Li X; Balk S
    Bioessays; 2018 Oct; 40(10):e1800057. PubMed ID: 30101540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polydopamine-mediated bio-inspired synthesis of copper sulfide nanoparticles for T
    Xiong Y; Sun F; Zhang Y; Yang Z; Liu P; Zou Y; Yu Y; Tong F; Yi C; Yang S; Xu Z
    Colloids Surf B Biointerfaces; 2019 Jan; 173():607-615. PubMed ID: 30359959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics.
    Zheng X; Zhang F; Zhao Y; Zhang J; Dawulieti J; Pan Y; Cui L; Sun M; Shao D; Li M; He K; Zhang M; Li J; Chen L
    Theranostics; 2018; 8(14):3808-3823. PubMed ID: 30083261
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Li C; Yang XQ; Zhang MZ; Song YY; Cheng K; An J; Zhang XS; Xuan Y; Liu B; Zhao YD
    Theranostics; 2018; 8(20):5662-5675. PubMed ID: 30555572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-time near-infrared bioimaging of a receptor-targeted cytotoxic dendritic theranostic agent.
    Wu J; Zhou Y; Li S; Qu D; Zhu WH; Tian H
    Biomaterials; 2017 Mar; 120():1-10. PubMed ID: 28011190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
    Jiao Y; Sun Y; Tang X; Ren Q; Yang W
    Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
    Shi J; Xiao Z; Kamaly N; Farokhzad OC
    Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Theranostic System Based on Endoglin Aptamer Conjugated Fluorescent Silica Nanoparticles.
    Tan J; Yang N; Zhong L; Tan J; Hu Z; Zhao Q; Gong W; Zhang Z; Zheng R; Lai Z; Li Y; Zhou C; Zhang G; Zheng D; Zhang Y; Wu S; Jiang X; Zhong J; Huang Y; Zhou S; Zhao Y
    Theranostics; 2017; 7(19):4862-4876. PubMed ID: 29187909
    [No Abstract]   [Full Text] [Related]  

  • 38. A review of NIR dyes in cancer targeting and imaging.
    Luo S; Zhang E; Su Y; Cheng T; Shi C
    Biomaterials; 2011 Oct; 32(29):7127-38. PubMed ID: 21724249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging.
    Yang Z; Song J; Tang W; Fan W; Dai Y; Shen Z; Lin L; Cheng S; Liu Y; Niu G; Rong P; Wang W; Chen X
    Theranostics; 2019; 9(2):526-536. PubMed ID: 30809290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy.
    Li X; Schumann C; Albarqi HA; Lee CJ; Alani AWG; Bracha S; Milovancev M; Taratula O; Taratula O
    Theranostics; 2018; 8(3):767-784. PubMed ID: 29344305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.